8435 related articles for article (PubMed ID: 2159436)
21. Dinitrophenyl-modified autologous melanoma vaccine induces a T cell response to hapten-modified, melanoma peptides.
Sato T; Bullock TN; Eisenlohr LC; Mastrangelo MJ; Berd D
Clin Immunol Immunopathol; 1997 Dec; 85(3):265-72. PubMed ID: 9400626
[TBL] [Abstract][Full Text] [Related]
22. Restoration of alloreactivity of melanoma by transduction with B7.1.
Brady MS; Lee F; Eckels DD; Ree SY; Latouche JB; Lee JS
J Immunother; 2000; 23(3):353-61. PubMed ID: 10838664
[TBL] [Abstract][Full Text] [Related]
23. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1.
Wölfel T; Schneider J; Meyer Zum Büschenfelde KH; Rammensee HG; Rötzschke O; Falk K
Int J Cancer; 1994 May; 57(3):413-8. PubMed ID: 8169004
[TBL] [Abstract][Full Text] [Related]
24. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
25. Western blot analysis of antigens on melanoma cells recognized by cytotoxic T cells.
Hersey P; MacDonald M; Werkman H
J Natl Cancer Inst; 1988 Aug; 80(11):826-35. PubMed ID: 3260628
[TBL] [Abstract][Full Text] [Related]
26. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
Kharkevitch DD; Seito D; Balch GC; Maeda T; Balch CM; Itoh K
Int J Cancer; 1994 Aug; 58(3):317-23. PubMed ID: 7914181
[TBL] [Abstract][Full Text] [Related]
27. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
28. HLA-B-restricted, CD8+ cytolytic human T cell clones derived from a melanoma-invaded lymph node.
Nakashima M; Watanabe T; Koprowski H; Steplewski Z
Hybridoma; 1996 Apr; 15(2):147-54. PubMed ID: 8743295
[TBL] [Abstract][Full Text] [Related]
29. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.
Sulé-Suso J; Arienti F; Melani C; Colombo MP; Parmiani G
Eur J Immunol; 1995 Oct; 25(10):2737-42. PubMed ID: 7589065
[TBL] [Abstract][Full Text] [Related]
30. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR
J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
[TBL] [Abstract][Full Text] [Related]
32. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
[TBL] [Abstract][Full Text] [Related]
33. Purification and partial characterization of a shed 66 kDa melanoma-associated antigen identified by autologous antibody.
Vlock DR; Aul DJ; Toporowicz A; McCoy JP; Brown WE
Biochim Biophys Acta; 1991 Oct; 1080(1):1-10. PubMed ID: 1932077
[TBL] [Abstract][Full Text] [Related]
34. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
35. Activation of autoreactive cytolytic T lymphocyte clone against human melanoma by anti-T3 monoclonal antibody and autologous accessory cells.
Tatake RJ; Guha A; Mukherji B
Cell Immunol; 1987 Aug; 108(1):42-52. PubMed ID: 3111724
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
37. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells.
Issekutz T; Chu E; Geha RS
J Immunol; 1982 Oct; 129(4):1446-50. PubMed ID: 6286767
[TBL] [Abstract][Full Text] [Related]
38. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ
J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165
[TBL] [Abstract][Full Text] [Related]
39. Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus.
Yee C; Gilbert MJ; Riddell SR; Brichard VG; Fefer A; Thompson JA; Boon T; Greenberg PD
J Immunol; 1996 Nov; 157(9):4079-86. PubMed ID: 8892642
[TBL] [Abstract][Full Text] [Related]
40. Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro.
Dunnion DJ; Cywinski AL; Tucker VC; Murray AK; Rickinson AB; Coulie P; Browning MJ
Immunology; 1999 Dec; 98(4):541-50. PubMed ID: 10594686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]